Story
ResMed Stock Slides After Tepid Guidance Overshadows EPS Beat

ResMed (RMD) shares fell sharply in pre-market trading Friday after the sleep and respiratory care device maker issued a cautious growth forecast that overshadowed a fourth-quarter earnings beat. The company's inaugural full-year guidance signaled a significant slowdown, disappointing investors and triggering a series of analyst price target cuts.
Mixed Results and Weak Forecast
For its fiscal fourth quarter, ResMed reported a non-GAAP earnings per share of $2.95, a 16% year-over-year increase that narrowly beat the consensus estimate of approximately $2.89. However, quarterly revenue of $1.46 billion fell just shy of Wall Street's expectation for $1.47 billion.
The more significant concern for investors was the company's first-ever full-year guidance. ResMed projected core revenue growth of just 5% to 7% for fiscal 2027, a marked deceleration from the 8% constant-currency growth it achieved in fiscal 2026. This outlook includes an anticipated $75 million revenue headwind related to a field safety action on its Astral ventilator line.
Compounding Headwinds
AdAdding to the pressure on future earnings, ResMed noted two other factors expected to be dilutive to EPS in the upcoming year. These include the pending divestiture of its MatrixCare software business and the recently closed $340 million acquisition of Noctrix Health.
The combination of the revenue miss and the weaker-than-expected outlook prompted several Wall Street analysts, including those at RBC Capital and Wells Fargo, to trim their price targets on the stock. The pre-market decline of 5.5% was entirely company-specific, as the broader S&P 500 was trading flat.
Market Impact
The sell-off pushed ResMed shares, which closed the prior session at $223.24, toward the lower end of their 52-week range of $180.26 to $293.81. The negative investor reaction underscores the market's focus on forward-looking growth, with the cautious guidance outweighing the modest earnings outperformance in the most recent quarter.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.